sachet and lozenge packaging

Dermalaczyn®

Probiotic Solution for Pediatric Atopic Dermatitis

target group infants and childrenfor infants and children

How it works

Targeting the most common allergic disease in children, Dermalaczyn® is a unique combination of patented probiotic strains specifically selected for the treatment of atopic dermatitis and for restoring the allergic immune system. 

And it’s fortified with vitamin D to strengthen the normal function of the immune system and inflammatory response. Dermalaczyn® boasts a 50% reduction in allergy symptoms such as pruritus, sleep loss, redness and swelling, as well as a reduction in emotional stress. 

An alternative therapy or taken in addition to corticosteroids, it is clinically tested with a high acceptance in children and is a pharmacy exclusive.


Facts

One randomized, placebo-controlled clinical trial (RCT) demonstrated significant reduction in clinical symptoms of atopic dermatitis in children. And 3 more RCTs demonstrated reduction in other allergy symptoms. 

It has been shown to timulate the Th1 immune response (INF-γ) and reduces key mediators (IL-4 & IgE) of allergic response, while vitamin D helps alleviate symptoms of atopic dermatitis.


How to use

In lozenge form for children above the age of 3, or as a once-a-day sachet for children under the age of 3. 

It can be taken as a standalone treatment, or in addition to emollient & topical corticosteroids, or other pharmacotherapy.

Dermalaczyn® is a registered trademark of Bluestone Pharma GmbH